Omega Therapeutics Ownership | Who Owns Omega Therapeutics?


OverviewForecastRevenueFinancialsChart

Omega Therapeutics Ownership Summary


Omega Therapeutics is owned by 91.62% institutional investors, 1.62% insiders, and 6.76% retail investors. Flagship pioneering is the largest institutional shareholder, holding 52.99% of OMGA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 5.01% of its assets in Omega Therapeutics shares.

OMGA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOmega Therapeutics91.62%1.62%6.76%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering29.23M52.99%$60.50M
Fmr6.24M11.32%$12.92M
Harbourvest partners3.51M6.37%$7.27M
State of wisconsin investment board1.86M3.37%$3.84M
Artal group1.32M2.40%$2.74M
Vanguard group1.11M2.02%$2.31M
Blue owl capital lp1.06M1.91%$2.19M
Millennium management754.22K1.37%$1.56M
683 capital management600.00K1.09%$1.24M
Blackrock363.95K0.66%$753.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering29.23M7.17%$60.50M
Harbourvest partners3.51M3.87%$7.27M
72 investment352.94K1.84%$730.59K
Blue owl capital lp1.06M0.61%$2.19M
Long corridor asset management85.00K0.17%$175.95K
683 capital management600.00K0.09%$1.24M
Artal group1.32M0.07%$2.74M
Platinum investment management346.35K0.03%$716.95K
Xtx topco83.94K0.01%$173.75K
Murphy pohlad asset management16.50K0.01%$34.16K

Top Buyers

HolderShares% AssetsChange
683 capital management600.00K0.09%485.00K
Millennium management754.22K0.00%427.08K
Squarepoint ops222.40K0.00%222.40K
Goldman sachs group190.11K0.00%168.04K
Renaissance128.40K0.00%128.40K

Top Sellers

HolderShares% AssetsChange
Blackrock363.95K--1.05M
Platinum investment management346.35K0.03%-540.43K
Citigroup9.57K--469.50K
State street94.73K--386.85K
Jacobs levy equity management---279.46K

New Positions

HolderShares% AssetsChangeValue
Long corridor asset management85.00K0.17%85.00K$175.95K
Xtx topco83.94K0.01%83.94K$173.75K
Raymond james financial services advisors38.17K0.00%38.17K$79.01K
Certuity10.00K0.00%10.00K$20.70K
Steward partners investment advisory2.00K-2.00K$4.14K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-9.00
Nisa investment advisors-25.00
Farther finance advisors-38.00
Pnc financial services group-49.00
Russell investments group-116.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202468-6.85%50,530,006-1.19%911.07%29-21.62%2150.00%
Mar 31, 20247312.31%51,136,5801.80%921.12%3723.33%14-30.00%
Dec 31, 2023656.56%50,233,395-1.29%911.07%3011.11%2042.86%
Sep 30, 202361-1.61%50,889,925-0.40%921.07%27-18.18%14-
Jun 30, 2023621.64%51,093,9211.72%920.94%33-10.81%14100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl S2.76M5.01%17.68K
Fidelity Growth Compy Commingled Pl O2.75M4.98%-
Fidelity Growth Company Fund2.01M3.65%-4.27K
Vanguard Total Stock Mkt Idx Inv779.10K1.41%-
Fidelity Growth Company K6777.22K1.41%-13.41K
Fidelity Series Growth Company455.88K0.83%-
Vanguard Institutional Extnd Mkt Idx Tr309.87K0.56%-
Galileo - Biotech Innovation Fund S USD175.00K0.32%-
Fidelity Extended Market Index126.30K0.23%-510.00
Bridgeway Ultra-Small Company Market119.00K0.22%-25.00K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 02, 2023Young Richard A-Sell$40.00K
May 01, 2023Young Richard A-Sell$40.00K
Apr 06, 2023Young Richard A-Sell$40.00K
Mar 17, 2023Young Richard A-Sell$80.00K
Feb 27, 2023Flagship Pioneering Inc.-Buy$11.53M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q3--
2023 Q2-3

OMGA Ownership FAQ


Who Owns Omega Therapeutics?

Omega Therapeutics shareholders are primarily institutional investors at 91.62%, followed by 1.62% insiders and 6.76% retail investors. The average institutional ownership in Omega Therapeutics's industry, Biotech Stocks , is 44.97%, which Omega Therapeutics exceeds.

Who owns the most shares of Omega Therapeutics?

Omega Therapeutics’s largest shareholders are Flagship pioneering (29.23M shares, 52.99%), Fmr (6.24M shares, 11.32%), and Harbourvest partners (3.51M shares, 6.37%). Together, they hold 70.68% of Omega Therapeutics’s total shares outstanding.

Does Blackrock own Omega Therapeutics?

Yes, BlackRock owns 0.66% of Omega Therapeutics, totaling 363.95K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 753.38K$. In the last quarter, BlackRock decreased its holdings by -1.051M shares, a -74.29% change.

Who is Omega Therapeutics’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Omega Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.17% of its assets in 29.23M Omega Therapeutics shares, valued at 60.5M$.

Who is the top mutual fund holder of Omega Therapeutics shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Omega Therapeutics shares, with 5.01% of its total shares outstanding invested in 2.76M Omega Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools